This analysis included a number of genes known to be involved in cell motility, invasion and metastasis, suggesting that the increase in HIF2A expression by HER2 may drive these characteristics in patients with HER2-positive breast cancers and may explain the relationship between HIF2A expression and survival in these patients. The gene discussed is EPAS1; the disease is breast cancer.